Patient Reported Outcomes Following Percutaneous Lung Ablation

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07720102
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This study evaluates satisfaction with percutaneous ablation and any symptoms experienced before and after the procedure in patients with lung tumors.

Key Dates

First listed
Jul 22, 2026
Start date
Sep 1, 2026
Status verified
Jul 2026
Primary completion
Jul 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: Observational
    Patients complete surveys throughout the study.

Primary Outcome Measure

Symptom severity following percutaneous lung ablation [ Time Frame: Baseline (prior to ablation), 1 day, 3 days, 7 days, 1 month, 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Clinical Trials Referral Office
[email protected]
855-776-0015
Ahmad Parvinian, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies